PDA

View Full Version : Beating breast cancer with MISTLETOE.


Unregistered
12-24-2005, 01:07 PM
A seasonal story?

I attach a story from the UK press and some counter opinions.

As usual it is important to be cautious and impossible to draw conclusions without the full facts - it may not have been the mistletoe but the hormone treatment or someting else, or the mistletoe helped.

I attach some balancing abstract by way of background.


RB


http://www.mirror.co.uk/news/tm_obj...-name_page.html

24 December 2005
MY BREAST CANCER WAS CURED BY MISTLETOE
Mum's joy as Xmas plant kills tumour
By Jan Disley and Victoria Bone

JOYFUL Nicola Wicksteed celebrated a Christmas miracle yesterday - after beating breast cancer with MISTLETOE.

Three months after taking extract of the Christmas "kissing plant" combined with herbs, her 7cm-wide tumour has vanished.

She said: "I put it down to natural drugs supporting my immune system." Amazed doctors said her recovery was "remarkable". Property developer and mum Nicola, 50, learned, she had a tumour two years ago. Snubbing surgery and chemotherapy she injected herself with mistletoe, took Carctol - a remedy of eight Ayurvedic herbs - and had hormone therapy.

A month after starting the treatment, the tumour had halved. Two months later, her cells were back to normal. Nicola, of Windermere, Cumbria, said: "I discovered cancer patients in Germany have mistletoe treatment and wanted to give it a chance.

"I know chemotherapy can destroy cancer cells but it also attacks the immune system."

Nicola was helped by the Park Attwood Clinic, at Bewdley, Worcs. Dr Maurice Orange said: "Mistletoe and hormone therapy worked better than anyone hoped. The result was extraordinary.

Advertisement
Falk AdSolution

"There is nothing there at all now. It does not mean the cancer has completely gone, but Nicola is in full remission."

Mistletoe was first used in cancer therapy more than 80 years ago. It appears to stimulate the immune system while destroying cancer cells.

j.disley@mirror.co.uk

http://www.mayoclinic.com/health/mistletoe/AN01247


Mistletoe: A possible cancer treatment?
Q.
I've heard that mistletoe may help fight cancer. Is this true?
No name / No state
A.

The liquid extract from European mistletoe — which is different from American mistletoe — has long been used as an alternative cancer treatment in Europe. Proponents believe that certain substances in mistletoe may help boost the immune system and slow or stop cancer growth. However, published studies have had conflicting results.

In Europe, mistletoe extracts are prescription drugs that are given by injection. Mistletoe injections have not yet received approval in the United States. However, this may change. The National Institutes of Health is currently conducting a study to examine the safety and effectiveness of mistletoe injections, given in combination with the chemotherapy drug gemcitabine, as a cancer treatment.

It is important to note that you should never eat any part of a mistletoe plant or drink mistletoe extract because mistletoe is a poisonous plant. Ingesting mistletoe may cause vomiting, convulsions, seizures and even death. Keep mistletoe plants out of reach of children and pets.
MORE ON THIS TOPIC

* Complementary and alternative cancer treatment: Get the facts

RELATED
Articles

* Complementary and alternative cancer treatment: Get the facts
* Mastectomy: Surgery to treat or prevent breast cancer
* Lung cancer

Ask a Specialist

* Insulin potentiation therapy: A dangerous alternative cancer treatment
* Chemotherapy side effects: Coping with taste changes
* Chemotherapy: Can it cause diabetes?

Centers

* Breast Cancer Center
* Prostate Cancer Center
* Cancer Center

MayoClinic.com Bookstore

* 'Mayo Clinic Guide to Women's Cancers' (Hardcover)

ARTICLE TOOLS
Print
Larger type

more information

Dec 14, 2005
© 1998-2005 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "Mayo Clinic Health Information," "Reliable information for a healthier life" and the triple-shield Mayo logo are trademarks of Mayo Foundation for Medical Education and Research.

AN01247


http://www.bccancer.bc.ca/PPI/Uncon...orIscucin. htm

ABSTRACT

Unconventional Therapies - Iscador / Mistletoe / Viscumalbum / Plenosol / Helixor / Iscucin

Print this Page | Give us your feedback: take our Print Survey

The role of your cancer health professional is to create an environment of openness and trust, and to help in making informed decisions about alternative/complementary therapies. Collaboration will improve the safe integration of all therapies during your experience with cancer. The "Summary" and "Professional Evaluation / Critique" sections of this Unconventional manual are cited directly from the medical literature, and are intended to help in the objective evaluation of alternative/complementary therapies.

Summary
"Although there is laboratory evidence of biological activity that may be beneficial to cancer patients, the evidence of clinical benefit from human studies remains weak and inconclusive. Because of the absence of serious side effects and the limited evidence that mistletoe products may offer some therapeutic advantages, further research is warranted." (Kaegi)

There have been recent studies published that show that mistletoe extracts can inhibit metastasis, reduce size, and cause necrosis of induced tumours in rodents. These studies suggest that by stimulating the cells of the immune system the mistletoe extracts have this prophylactic effect. No evidence has been published to date showing that mistletoe extracts are effective in treating cancer in humans. (Yoon) (Weber) (Zarkovic) (Antony) (Kutton)

"Because the extract has relatively weak antineoplastic activity, it may be useful as an adjuvant therapy with surgery or radiotherapy. ... Some components have shown antineoplastic activity. However, additional clinical investigation is required to assess the plant's efficacy and long-term safety profile. Because I.V. mistletoe preparations are not standardized in the United States, it is unlikely that mistletoe will be considered for use as an antineoplastic agent in the near future." (Fetrow)

Esther
12-27-2005, 08:38 PM
I'm a very big supporter of Mistletoe. I order it from Germany in injectable form. I have been NED for a year now on just Herceptin and Iscador (mistletoe)

I am stage 4 with liver and bone mets that right now are showing no detectable signs on scans.

I have been using the Iscador for about a year, they also help to increase my energy. There was a study at the NIH last year that indicated that mistletoe worked synergistically with Herceptin.

Unregistered
12-30-2005, 05:24 AM
Do you have any more technical information - why it is claimed to work - trials - manifacturers links etc.


Many thanks,

RB

Unregistered
12-30-2005, 05:22 PM
Interesting.

Other sites question the reliability of the Iscador trials.

If it is the most commonly used oncological drug in Germany as reported patients and doctors are voting with their feet.

From a quick skim side effects are limited.

Reported benifits include general wellbeing and reduction of treatment side effects.

See also second trial link below.

RB




http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11347286&dopt=Citation


1: Altern Ther Health Med. 2001 May-Jun;7(3):57-66, 68-72, 74-6 passim. Related Articles, Links

Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study.

Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R.

Institute for Preventive Medicine, European Center for Peace and Development, United Nations, Heidelberg, Germany.

CONTEXT: In anthroposophical medicine, total extracts of Viscum album (mistletoe) have been developed to treat cancer patients. The oldest such product is Iscador. Although Iscador is regarded as a complementary cancer therapy, it is the most commonly used oncological drug in Germany. OBJECTIVE: To determine whether Iscador treatment prolongs survival time of patients with carcinoma of the colon, rectum, or stomach; breast carcinoma with or without axillary or remote metastases; or small cell or non-small-cell bronchogenic carcinoma; and to explore synergies between Iscador treatment and psychosomatic self-regulation. DESIGN: Prospective nonrandomized and randomized matched-pair studies nested within a cohort study. SETTING: General community in Germany. PARTICIPANTS: 10,226 cancer patients involved in a prospective long-term epidemiological cohort study, including 1668 patients treated with Iscador and 8475 who had taken neither Iscador nor any other mistletoe product (control patients). INTERVENTION: Iscador. MAIN OUTCOME MEASURE: Survival time. RESULTS: In the nonrandomized matched-pair study, survival time of patients treated with Iscador was longer for all types of cancer studied. In the pool of 396 matched pairs, mean survival time in the Iscador groups (4.23 years) was roughly 40% longer than in the control groups (3.05 years; P < .001). Synergies between Iscador treatment and self-regulation manifested in a longer survival advantage for Iscador patients with good self-regulation (56% relative to control group; P = .03) than for patients with poor self-regulation. Results of the 2 randomized matched-pair studies largely confirmed the results of the non-randomized studies. CONCLUSION: Iscador treatment can achieve a clinically relevant prolongation of survival time of cancer patients and appears to stimulate self-regulation.

http://articles.weleda.com/ArticleContentFiles/3_175.pdf

Rich
12-30-2005, 08:52 PM
Any lurking Oncs want to weigh in on this?

Unregistered
12-30-2005, 11:27 PM
Esther , may i ask where you order the mistletoe from? Could you give me address? My E-mail is HighPockets803@aol.com. God Bless and Thanks !

DeborahNC
12-31-2005, 08:22 AM
I would be interested to know how to order as well. I found the Iscador site, but the US link (Iscar) would not work for me.

I talked to my onc about this yesterday and as it is not FDA approved for use in US she has no experience with it. She did add that she feels Europe is much more progressive in research and treatment options.